| The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. | |
| | |
MedLine Citation:
|
PMID: 7441663 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A young woman with idiopathic temporal lobe epilepsy developed biopsy-proven oesinophilic fasciitis 16 months after the initiation of phenytoin therapy. Six months after withdrawal of this medication the fasciitis disappeared, and after 5 yr it has not recurred. This case highlights a possible association between the development of oesinophilic fasciitis and the use of medications such as phenytoin. |
| | |
Authors:
|
R R Buchanan; D A Gordon; T J Muckle; F McKenna; G Kraag |
Related Documents
:
|
23369273 - Xenon in medical area: emphasis on neuroprotection in hypoxia and anesthesia. 3798263 - Advantages of the new low-osmolar radiographic contrast media. 21837893 - Physician, monitor thyself: professionalism and accountability in the use of social media. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Journal of rheumatology Volume: 7 ISSN: 0315-162X ISO Abbreviation: J. Rheumatol. Publication Date: 1980 Sep-Oct |
Date Detail:
|
Created Date: 1981-02-19 Completed Date: 1981-02-19 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7501984 Medline TA: J Rheumatol Country: CANADA |
Other Details:
|
Languages: eng Pagination: 733-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Eosinophilia / chemically induced, complications* Epilepsy / drug therapy Fascia / pathology Fasciitis / chemically induced, complications* Female Humans Phenytoin / adverse effects*, therapeutic use Syndrome |
| Chemical | |
Reg. No./Substance:
|
57-41-0/Phenytoin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: SAA amyloid protein levels in amyloid-prone chronic inflammatory disorders. Lack of association with...
Next Document: Interlaboratory salicylate variability.